Related references
Note: Only part of the references are listed.Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
Katie Spencer et al.
LANCET ONCOLOGY (2021)
Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer
Brian C. Baumann et al.
JAMA ONCOLOGY (2020)
Acute toxicities after extremely hypofractionated radiotherapy for prostate cancer: lessons from HYPO-RT-PC and PACE-B
Jesus E. Juarez et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?
Timur Mitin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U. Kishan et al.
JAMA NETWORK OPEN (2019)
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M. Michalski et al.
JAMA ONCOLOGY (2018)
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
Scott C. Morgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review
M. Keyes et al.
BRACHYTHERAPY (2017)
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
Rupesh Kotecha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
Luca Incrocci et al.
LANCET ONCOLOGY (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
Assessing measures of comorbidity and functional status for risk adjustment to compare hospital performance for colorectal cancer surgery: a retrospective data-linkage study
Timothy A. Dobbins et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
Alan Jay Katz et al.
FRONTIERS IN ONCOLOGY (2014)
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Prostate alpha/beta revisited - an analysis of clinical results from 14 168 patients
Alexandru Dasu et al.
ACTA ONCOLOGICA (2012)
Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates
Jessica A. Myers et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
CONFIRMATION OF A LOW alpha/beta RATIO FOR PROSTATE CANCER TREATED BY EXTERNAL BEAM RADIATION THERAPY ALONE USING A POST-TREATMENT REPEATED-MEASURES MODEL FOR PSA DYNAMICS
Cecile Proust-Lima et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy
Raymond Miralbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Constructing inverse probability weights for marginal structural models
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
A simple analytic derivation suggests that prostate cancer α/β ratio is low
CR King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
